The global hepatitis E diagnostic tests market size reached a value of approximately USD 68.34 Billion in 2024. The market is further expected to grow at a CAGR of 4.40% between 2025 and 2034, reaching a value of USD 105.12 Billion by 2034.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
4.4%
Value in USD Billion
2025-2034
Hepatitis E Diagnostic Tests Market Outlook
*this image is indicative*
Hepatitis E is a condition in which the liver becomes inflamed as a result of an infection caused by the Hepatitis E Virus (HEV). Typically, HEV is transmitted through faecal-oral contamination, most often by drinking water contaminated by faecal matter. The diagnostic tests for hepatitis E are based on the detection of anti-HEV immunoglobulins.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of test type, the market is segmented into ELISA HEV IgM test, ELISA HEV IgG test, and RT-PCR test. Based on end-use, the market is divided into hospitals, and diagnostic centres, among others. By region, the market is classified into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global hepatitis E diagnostic tests market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.
According to the hepatitis E diagnostic tests market research, hospitals are expected to account for a major portion of the market for hepatitis E diagnostic tests over the forecast period. This is due to the fact that hospitals are able to integrate diagnostics and treatment with care coordination, which in turn results in faster recovery of the patient. Hospitals are also able to identify potential signs of the virus at an earlier stage, resulting in greater usage of hepatitis E diagnostic tests. Additionally, hospitals are able to provide services such as language assistance, dietary support, and post treatment care, which is contributing towards the growth of the segment in the market for hepatitis E diagnostic tests.
In terms of regions, the Asia Pacific holds a significant hepatitis E diagnostic tests market share owing to the heightened prevalence of hepatitis E in East and South Asia. The hyper-endemicity of the condition in the region, worsened by lack of safe drinking water and poor sanitation facilities, are resulting in an increased demand for hepatitis E diagnostic tests. Increasing awareness hepatitis E and overall improved healthcare knowledge are resulting in more people opting for diagnostic tests at earlier signs of symptoms. Heightened population density further increases the risk of spread of hepatitis E, particularly in regions with lack of adequate sanitation. Investments of governments in the region to improve healthcare infrastructure and diagnose and treat prevalent conditions at a faster pace are further supporting the market for hepatitis E diagnostic tests in the Asia Pacific.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
MP Biomedicals, LLC is a biotechnology research company that was established in 1959 and is headquartered in California, United States. Their dedicated team of researchers and scientists is on a quest for ground-breaking discoveries to improve lives and create a better world. The company sells and manufactures over 55,000 products across the globe.
F. Hoffmann-La Roche Ltd is a healthcare company based in Base, Switzerland, that was founded in 1896. The two major divisions of this multinational company are diagnostics and pharmaceuticals, with a wide range of focus areas including cardiometabolic diseases, haematology, infectious diseases, inflammatory bowel diseases, neuroscience, oncology, ophthalmology, rare diseases, and women’s health.
Altona Diagnostics GmbH is a medical diagnostic company that was established in 2007 and is headquartered in Hamburg, Germany. They are involved in the development and manufacture of in-vitro diagnostic tests for detection of viruses, parasites, and bacteria. With over 40 distribution partners, the company’s offerings include instruments and equipment, reagents, and products.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other market players include AccuBioTech Co., Ltd., Dia.Pro Diagnostic Bioprobes s.r.l, Beijing Wantai, Fortress Diagnostics, Mikrogen GmbH., Primerdesign Ltd, and Gold Standard Diagnostics, among others.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market size for hepatitis E diagnostic tests reached a value of approximately USD 68.34 Billion in 2024.
The market for hepatitis E diagnostic tests is expected to grow at a CAGR of 4.40% between 2025 and 2034.
The market for hepatitis E diagnostic tests is estimated to witness a healthy growth in the forecast period of 2025-2034 to reach USD 105.12 Billion by 2034.
The major market drivers include increasing prevalence of hepatitis E, improved availability of hepatitis E diagnostic tests, and increasing initiatives by various government across the globe to increase the knowledge about hepatitis E.
The key hepatitis E diagnostic tests market trends include shift towards molecular diagnostics from conventional testing methods, growing awareness about the advantages of regularly testing for hepatitis E virus, and increasing technological advancements.
The various end-uses in the market are hospitals, and diagnostic centres, among others.
The symptoms of hepatitis E can include lack of appetite, fatigue, jaundice, nausea, and stomach pain, however, in many cases, particularly young children, hepatitis E can be asymptomatic.
The significant test types in the market are ELISA HEV IgM test, ELISA HEV IgG test, and RT-PCR test.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The key players in the global hepatitis E diagnostic tests market are MP Biomedicals, LLC, F. Hoffmann-La Roche Ltd, Altona Diagnostics GmbH, AccuBioTech Co., Ltd., Dia.Pro Diagnostic Bioprobes s.r.l, Beijing Wantai, Fortress Diagnostics, Mikrogen GmbH., Primerdesign Ltd, and Gold Standard Diagnostics, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by End-Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
